Solventum Corp. (SOLV)
71.25
+2.37
(+3.44%)
USD |
NYSE |
Apr 17, 10:43
Solventum Research and Development Expense (Quarterly) : 168.00M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Align Technology, Inc. | 83.04M |
| Envista Holdings Corp. | 32.10M |
| Boston Scientific Corp. | 569.00M |
| Dentsply Sirona, Inc. | 40.00M |
| Sonendo, Inc. | 1.413M |